Hepatitis B virus infection, The Lancet, vol.373, pp.582-592, 2009. ,
Comparison of the long-term efficacy between entecavir and tenofovir in treatment-naïve chronic hepatitis B patients, BMC Gastroenterol, vol.17, p.39, 2017. ,
Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis, World J Gastroenterol WJG, vol.21, pp.7869-7876, 2015. ,
, HBV strain with mutations conferring resistance to both lamivudine and adefovir
, Hepatol Baltim Md, vol.41, pp.1391-1398
Inhibition of Hepatitis B Virus Polymerase by Entecavir, J Virol, vol.81, pp.3992-4001, 2007. ,
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine, Antivir Ther, vol.20, pp.779-787, 2015. ,
Resistance mutations of hepatitis B virus in entecavir-refractory patients, Hepatol Commun, vol.1, pp.110-121, 2017. ,
Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice, Emerg Microbes Infect, vol.8, pp.354-365, 2019. ,
Characterization of novel entecavir resistance mutations, J Hepatol, vol.63, pp.546-553, 2015. ,
Trends in Hepatitis B Virus Resistance to Nucleoside/Nucleotide Analogs in North China from 2009 to 2016: A Retrospective Study, Int J Antimicrob Agents, vol.0, 2018. ,
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection, Hepatology, vol.34, pp.578-582, 2001. ,
Safety and efficacy of entecavir for the treatment of chronic hepatitis B, Infect Drug Resist, vol.4, pp.55-64, 2011. ,
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients, Gastroenterology, vol.129, pp.1198-1209, 2005. ,
Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy, Virus Genes, vol.47, pp.1-9, 2013. ,
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy, Hepatology, vol.49, pp.1503-1514, 2009. ,
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient, J Hepatol, vol.39, pp.1085-1089, 2003. ,
Hepatitis B Virus Drug Resistance Tools: One Sequence, Two Predictions, Intervirology, vol.57, pp.232-236, 2014. ,
Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation, Clin Infect Dis, vol.42, pp.1608-1618, 2006. ,
Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients, Diagn Microbiol Infect Dis, vol.70, pp.91-100, 2011. ,
Analysis of the Cytosolic Domains of the Hepatitis B Virus Envelope Proteins for Their Function in Viral Particle Assembly and Infectivity, J Virol, vol.80, pp.11935-11945, 2006. ,
In Vitro Phenotyping of Recombinant Hepatitis B Virus Containing the Polymerase/Reverse Transcriptase Gene from Clinical IsolatesAntiviral Methods and Protocols, 2013. ,
Growth of human hepatoma cell lines with differentiated functions in chemically defined medium, Cancer Res, vol.42, pp.3858-3863, 1982. ,
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine, Antimicrob Agents Chemother, vol.48, pp.3498-3507, 2004. ,
Phenotypic assay of a hepatitis B virus strain carrying an rtS246T variant using a new strategy, J Med Virol, vol.84, pp.34-43, 2012. ,
Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance, Hepatology, vol.47, pp.1473-1482, 2008. ,